The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
A Systematic Review of miR-29 in Cancer
Open accessAbstract
MicroRNAs (miRNA) are small non-coding RNAs (∼22 nt in length) that are known as potent master regulators of eukaryotic gene expression. miRNAs have been shown to play a critical role in cancer pathogenesis, and the misregulation of miRNAs is a well-known feature of cancer. In recent years, miR-29 has emerged as a critical miRNA in various cancers, and it has been shown to regulate multiple oncogenic processes, including epigenetics, proteostasis, metabolism, proliferation, apoptosis, metastasis, fibrosis, angiogenesis, and immunomodulation. Although miR-29 has been thoroughly documented as a tumor suppressor in the majority of studies, some controversy remains with conflicting reports of miR-29 as an oncogene. In this review, we provide a systematic overview of miR-29's functional role in various mechanisms of cancer and introspection on the contradictory roles of miR-29.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family
Chen, L., Zhang, S., Wu, J., Cui, J., Zhong, L., Zeng, L., & Ge, S. (2017) · Oncogene · doi:10.1038/onc.2017.89 · Cited by 392
RetractedZhang, X., Zhao, X., Fiskus, W., Lin, J., Lwin, T., Rao, R., Zhang, Y., Chan, J. C., Fu, K., Marquez, V. E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.003 · Cited by 276
RetractedGao, S., Cheng, C., Chen, H., Li, M., Liu, K., & Wang, G. (2016) · Journal of Molecular Histology · doi:10.1007/s10735-016-9659-2 · Cited by 27
RetractedRetracted : MicroRNA‐29a inhibits proliferation and motility of schwannoma cells by targeting CDK6
Ma, J., Li, T., Yuan, H., Han, X., Shui, S., Guo, D., & Yan, L. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26426 · Cited by 15
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Predicting effective microRNA target sites in mammalian mRNAs
Agarwal, V., Bell, G. W., Nam, J.-W., & Bartel, D. P. (2015) · eLife · doi:10.7554/elife.05005 · Cited by 7,318 · cited 1×
“Accordingly, evolutionarily conserved miRNAs sharing analogous seed sequences have been organized into 87 distinct miRNA families.(34) One of these miRNA families, miR-29, consists of three members, miR-29a, miR-29b, and miR-29c.”
BackgroundConversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,373
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 1×
“Hence, targeting the miR-29 family and TGF-b may be an effective strategy for the treatment and management of fibrosis.(181,182) The interaction between the miR-29 family and TGF-b was revealed in lung and cardiac fibroses.”
BackgroundMatrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846 · cited 1×
“Genomic heterogeneity is a well-known feature of cancer exists between tumors of different patients and is even evident within the same tumor.(240) In recent years, there has been a paradigm shift toward classifying cancers based on genetic alterations rather than in the context of anatomical location.”
BackgroundA Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626 · cited 1×
“In the case of miR29, the miR-29-3p arm represents the most abundant and functionally relevant arm of all three family members.(32,33) Following its association within RISC, miRNAs function through a 6-8-mer sequence, known as a seed sequence, that complementarily binds to the 30 UTR of mRNA transcripts through canoni…”
BackgroundRegulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · cited 2×
“In lung cancer, a study profiling the miRNA expression levels in tumor biopsies foundmiR-29b to be one of the most significantly downregulated miRNAs.(218) Consistently, another study sought to define molecular features that distinguish lung squamous cell carcinoma versus adenocarcinoma, and the researchers found that…”
BackgroundResultApoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836 · cited 1×
“Critical changes may occur at any point along these pathways, leading to tumorigenesis, metastasis, and resistance to anticancer drugs.(131,132) A large body of experimental evidence documents that miRNAs function as important regulators of cancer cell death.”
BackgroundThe molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y.-F., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,770
Nuclear Export of MicroRNA Precursors
Lund, E., Güttinger, S., Calado, A., Dahlberg, J. E., & Kutay, U. (2004) · Science · doi:10.1126/science.1090599 · Cited by 2,714
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · cited 1×
“However, increasing evidence suggests a greater level of complexity to the story, as the stroma was shown to restrain tumor growth in preclinical studies.(176,177) Recent work has demonstrated that the reductionist approach of all or nothing may not be the appropriate means of targeting the stroma, rather a more subtl…”
BackgroundStromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085
Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D. L., Fire, A., Ruvkun, G., & Mello, C. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00431-7 · Cited by 1,908
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,768
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
Integrins: Emerging Paradigms of Signal Transduction
Schwartz, M. A., Schaller, M. D., & Ginsberg, M. H. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.003001 · Cited by 1,594
SREBP transcription factors: master regulators of lipid homeostasis
Eberlé, D., Hegarty, B., Bossard, P., Ferré, P., & Foufelle, F. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.018 · Cited by 1,529
Mechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498 · cited 1×
“Earlier work demonstrated that pancreatic cancer cells heavily upregulated autophagy for survival and that this upregulation also conferred chemoresistance against a nucleoside analog, gemcitabine.(87) miR-29a was significantly downregulated in pancreatic cancer cells, and miR-29a overexpression led to increased gemci…”
BackgroundMicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,434
Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs
Bartel, D. P., & Chen, C.-Z. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1328 · Cited by 1,425
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183
Waddington, C. H. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr184 · Cited by 1,082
Autophagy at the crossroads of catabolism and anabolism
Kaur, J., & Debnath, J. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4024 · Cited by 991
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
Kanzawa, T., Germano, I. M., Komata, T., Ito, H., Kondo, Y., & Kondo, S. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401359 · Cited by 986
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936 · cited 1×
“In fact, several CDK6 inhibitors have been developed to target proliferating cancer cells.(104)CDK6 has been shown to be a direct target ofmiR-29 in several malignancies, including mantle cell lymphoma,(105) acute myeloid leukemia (AML),(106) and cervical cancer.”
BackgroundGenetic and transcriptional evolution alters cancer cell line drug response
Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C. A., Dempster, J., Lyons, N. J., Burns, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0409-3 · Cited by 931 · cited 2×
“A potential explanation for these confounding results could be explained by recent reports demonstrating heterogeneity between the same cell line from different labs.(239) 27 strains of the same well-utilized cell line MCF7 demonstrated immense genetic diversity and a large variability in drug response.”
ResultHistone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
MiR-15a and miR-16-1 cluster functions in human leukemia
Calin, G. A., Cimmino, A., Fabbri, M., Ferracin, M., Wojcik, S. E., Shimizu, M., Taccioli, C., Zanesi, N., Garzon, R., Aqeilan, R. I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800121105 · Cited by 808
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
Roderburg, C., Urban, G.-W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., et al. (2011) · Hepatology · doi:10.1002/hep.23922 · Cited by 803
Biological principles of microRNA-mediated regulation: shared themes amid diversity
Flynt, A. S., & Lai, E. C. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2455 · Cited by 783
Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C. E. A., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170589 · Cited by 781
Tumor-associated stromal cells as key contributors to the tumor microenvironment
Bussard, K. M., Mutkus, L., Stumpf, K., Gomez-Manzano, C., & Marini, F. C. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0740-2 · Cited by 746 · cited 4×
“Fibrosis is a complex process that involves excessive deposition and reorganization of the ECM, leading to EMT.175 Primarily, fibrosis is mediated by cancer cells that activate fibroblasts, where activated fibroblasts then further perpetuate sustained activation of themselves and other neighboring fibroblasts175 and l…”
BackgroundInfluentialHeerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
Chakraborty, C., Sharma, A. R., Sharma, G., Doss, C. G. P., & Lee, S.-S. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.06.005 · Cited by 731
A Hexanucleotide Element Directs MicroRNA Nuclear Import
Hwang, H.-W., Wentzel, E. A., & Mendell, J. T. (2007) · Science · doi:10.1126/science.1136235 · Cited by 696
GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary Gland
Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D., & Werb, Z. (2006) · Cell · doi:10.1016/j.cell.2006.09.048 · Cited by 688
The Role of Angiogenesis in Cancer Treatment
Rajabi, M., & Mousa, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020034 · Cited by 656
Ma, F., Xu, S., Liu, X., Zhang, Q., Xu, X., Liu, M., Hua, M., Li, N., Yao, H., & Cao, X. (2011) · Nature Immunology · doi:10.1038/ni.2073 · Cited by 641
miR-29 miRNAs activate p53 by targeting p85α and CDC42
Park, S.-Y., Lee, J. H., Ha, M., Nam, J.-W., & Kim, V. N. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1533 · Cited by 606
The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine
Pratt, A. J., & MacRae, I. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900012200 · Cited by 602
Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis
Kim, H., Tu, H.-C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J.-D., & Cheng, E. H.-Y. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.030 · Cited by 600 · cited 1×
“It activates an apoptotic cascade by facilitating Bax activation, causing cytochrome c release from the mitochondria, caspase-3 activation, and DNA fragmentation.(141,142) It was also found that miR-29 could target pro-apoptotic PUMA protein and protect against ischemia-reperfusion injury, suggesting that PUMA might b…”
BackgroundCaretti, G., Di Padova, M., Micales, B., Lyons, G. E., & Sartorelli, V. (2004) · Genes & Development · doi:10.1101/gad.1241904 · Cited by 600
NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma
Wang, H., Garzon, R., Sun, H., Ladner, K. J., Singh, R., Dahlman, J., Cheng, A., Hall, B. M., Qualman, S. J., Chandler, D. S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.006 · Cited by 593
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Picarda, E., Ohaegbulam, K. C., & Zang, X. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2428 · Cited by 582
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
PUMA mediates the apoptotic response to p53 in colorectal cancer cells
Yu, J., Wang, Z., Kinzler, K. W., Vogelstein, B., & Zhang, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627984100 · Cited by 563
Post-transcriptional control of miRNA biogenesis
Michlewski, G., & Cáceres, J. F. (2019) · RNA · doi:10.1261/rna.068692.118 · Cited by 563
Gravdal, K., Halvorsen, O. J., Haukaas, S. A., & Akslen, L. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1263 · Cited by 562
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
Indran, I. R., Tufo, G., Pervaiz, S., & Brenner, C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.03.010 · Cited by 526
Blocked Autophagy Sensitizes Resistant Carcinoma Cells to Radiation Therapy
Apel, A., Herr, I., Schwarz, H., Rodemann, H. P., & Mayer, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-0562 · Cited by 523
miR-29 Is a Major Regulator of Genes Associated with Pulmonary Fibrosis
Cushing, L., Kuang, P. P., Qian, J., Shao, F., Wu, J., Little, F., Thannickal, V. J., Cardoso, W. V., & Lü, J. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0323oc · Cited by 502
Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis
Wang, B., Komers, R., Carew, R., Winbanks, C. E., Xu, B., Herman-Edelstein, M., Koh, P., Thomas, M., Jandeleit-Dahm, K., Gregorevic, P., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010055 · Cited by 498
Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations
Yang, A., Rajeshkumar, N. V., Wang, X., Yabuuchi, S., Alexander, B. M., Chu, G. C., Von Hoff, D. D., Maitra, A., & Kimmelman, A. C. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0362 · Cited by 486
MicroRNA 29b functions in acute myeloid leukemia
Garzon, R., Heaphy, C. E. A., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., Zanesi, N., Kornblau, S. M., Marcucci, G., Calin, G. A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211938 · Cited by 459
YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., & Guan, K.-L. (2012) · Nature Cell Biology · doi:10.1038/ncb2615 · Cited by 453
Developing MicroRNA Therapeutics
van Rooij, E., Purcell, A. L., & Levin, A. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247916 · Cited by 449
Chou, J., Lin, J. H., Brenot, A., Kim, J.-W., Provot, S., & Werb, Z. (2013) · Nature Cell Biology · doi:10.1038/ncb2672 · Cited by 373
GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model
Kouros-Mehr, H., Bechis, S. K., Slorach, E. M., Littlepage, L. E., Egeblad, M., Ewald, A. J., Pai, S.-Y., Ho, I.-C., & Werb, Z. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.011 · Cited by 372
Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse
Kaufmann, S. H., Karp, J. E., Svingen, P. A., Krajewski, S., Burke, P. J., Gore, S. D., & Reed, J. C. (1998) · Blood · doi:10.1182/blood.v91.3.991 · Cited by 365
MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-γ Production in Helper T Cells
Steiner, D. F., Thomas, M. F., Hu, J. K., Yang, Z., Babiarz, J. E., Allen, C. D. C., Matloubian, M., Blelloch, R., & Ansel, K. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.009 · Cited by 365
Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Girault, I., Tozlu, S., Lidereau, R., & Bièche, I. (2003) · PubMed · Cited by 358
Recent Advances in Nanomaterials for Gene Delivery—A Review
Riley, M., & Vermerris, W. (2017) · Nanomaterials · doi:10.3390/nano7050094 · Cited by 354
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2002 · Cited by 344
Zhao, J.-J., Lin, J., Lwin, T., Yang, H., Guo, J., Kong, W., Dessureault, S., Moscinski, L. C., Rezania, D., Dalton, W. S., et al. (2010) · Blood · doi:10.1182/blood-2009-09-243147 · Cited by 335
MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
Landi, M. T., Zhao, Y., Rotunno, M., Koshiol, J., Liu, H., Bergen, A. W., Rubagotti, M., Goldstein, A. M., Linnoila, I., Marincola, F. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1736 · Cited by 321
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
Cheng, C., Ru, P., Geng, F., Liu, J., Yoo, J. Y., Wu, X., Cheng, X., Euthine, V., Hu, P., Guo, J. Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.021 · Cited by 320
Migrating into the tumor: a roadmap for T cells
van der Woude, L. L., Gorris, M. A. J., Halilovic, A., Figdor, C. G., & de Vries, I. J. M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.09.006 · Cited by 307
Fang, J.-H., Zhou, H.-C., Zeng, C., Yang, J., Liu, Y., Huang, X., Zhang, J.-P., Guan, X.-Y., & Zhuang, S.-M. (2011) · Hepatology · doi:10.1002/hep.24577 · Cited by 307
Akalay, I., Janji, B., Hasmim, M., Noman, M. Z., André, F., De Cremoux, P., Bertheau, P., Badoual, C., Vielh, P., Larsen, A. K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2432 · Cited by 302
Proteasome inhibitors in cancer therapy
Crawford, L. J., Walker, B., & Irvine, A. E. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0121-7 · Cited by 299
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Xiao, J., Meng, X.-M., Huang, X. R., Chung, A. C., Feng, Y.-L., Hui, D. S., Yu, C.-M., Sung, J. J., & Lan, H. Y. (2012) · Molecular Therapy · doi:10.1038/mt.2012.36 · Cited by 293
Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB
Mott, J. L., Kurita, S., Cazanave, S. C., Bronk, S. F., Werneburg, N. W., & Fernandez‐Zapico, M. E. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22630 · Cited by 282
Li, J., Yang, B., Zhou, Q., Wu, Y., Shang, D., Guo, Y., Song, Z., Zheng, Q., & Xiong, J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt063 · Cited by 280
Mutation of GATA3 in human breast tumors
Usary, J., Llaca, V., Karaca, G., Presswala, S., Karaca, M., He, X., Langerød, A., Kåresen, R., Oh, D. S., Dressler, L. G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207966 · Cited by 277
E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes
Di Stefano, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg613 · Cited by 274
Xu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4517 · Cited by 264
Alternative mechanisms of miR-34a regulation in cancer
Slabáková, E., Culig, Z., Remšík, J., & Souček, K. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.495 · Cited by 264
Roy, L. D., Sahraei, M., Subramani, D. B., Besmer, D., Nath, S., Tinder, T. L., Bajaj, E., Shanmugam, K., Lee, Y. Y., Hwang, S. I. L., et al. (2011) · Oncogene · doi:10.1038/onc.2010.526 · Cited by 263
MicroRNA regulation of core apoptosis pathways in cancer
Lima, R. T., Busacca, S., Almeida, G. M., Gaudino, G., Fennell, D. A., & Vasconcelos, M. H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.005 · Cited by 260
Saito, Y., Kanai, Y., Nakagawa, T., Sakamoto, M., Saito, H., Ishii, H., & Hirohashi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11127 · Cited by 259
Pullen, T. J., da Silva Xavier, G., Kelsey, G., & Rutter, G. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01433-10 · Cited by 258
Wong, C. C.-L., Tse, A. P.-W., Huang, Y.-P., Zhu, Y.-T., Chiu, D. K.-C., Lai, R. K.-H., Au, S. L.-K., Kai, A. K.-L., Lee, J. M.-F., Wei, L. L., et al. (2014) · Hepatology · doi:10.1002/hep.27320 · Cited by 253
MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation
Dawson, K., Wakili, R., Ördög, B., Clauss, S., Chen, Y., Iwasaki, Y., Voigt, N., Qi, X. Y., Sinner, M. F., Dobrev, D., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001207 · Cited by 252
Lin, R.-K., Hsu, H.-S., Chang, J.-W., Chen, C.-Y., Chen, J.-T., & Wang, Y.-C. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.10.022 · Cited by 246
Cell proliferation and cell cycle control: a mini review
Golias, C. H., Charalabopoulos, A., & Charalabopoulos, K. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00284.x · Cited by 243
Liu, Y., Taylor, N. E., Lu, L., Usa, K., Cowley, A. W., Ferreri, N. R., Yeo, N. C., & Liang, M. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.144428 · Cited by 235
DNA methyltransferase and demethylase in human prostate cancer
Patra, S. K., Patra, A., Zhao, H., & Dahiya, R. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10033 · Cited by 234
Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling
Sassi, Y., Avramopoulos, P., Ramanujam, D., Grüter, L., Werfel, S., Giosele, S., Brunner, A.-D., Esfandyari, D., Papadopoulou, A. S., De Strooper, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01737-4 · Cited by 234
Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
Wang, H., Jiang, Y., Peng, H., Chen, Y., Zhu, P., & Huang, Y. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.031 · Cited by 231
Donadelli, M., Dando, I., Zaniboni, T., Costanzo, C., Dalla Pozza, E., Scupoli, M. T., Scarpa, A., Zappavigna, S., Marra, M., Abbruzzese, A., et al. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.36 · Cited by 228
Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
Robbins, M., Judge, A., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.131 · Cited by 220
Hiroki, E., Akahira, J., Suzuki, F., Nagase, S., Ito, K., Suzuki, T., Sasano, H., & Yaegashi, N. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01385.x · Cited by 214
Identification of a gene expression signature associated with pediatric AML prognosis
Yagi, T. (2003) · Blood · doi:10.1182/blood-2003-02-0578 · Cited by 209
Bakkar, N., Wang, J., Ladner, K. J., Wang, H., Dahlman, J. M., Carathers, M., Acharyya, S., Rudnicki, M. A., Hollenbach, A. D., & Guttridge, D. C. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200707179 · Cited by 208
Li, Y., Wang, F., Xu, J., Ye, F., Shen, Y., Zhou, J., Lu, W., Wan, X., Ma, D., & Xie, X. (2011) · The Journal of Pathology · doi:10.1002/path.2873 · Cited by 201
Analysis of microRNA-target interactions across diverse cancer types
Jacobsen, A., Silber, J., Harinath, G., Huse, J. T., Schultz, N., & Sander, C. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2678 · Cited by 196
The ubiquitin-proteasome system and autophagy: Coordinated and independent activities
Cohen-Kaplan, V., Livneh, I., Avni, N., Cohen-Rosenzweig, C., & Ciechanover, A. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.019 · Cited by 196
Massart, J., Sjögren, R. J. O., Lundell, L. S., Mudry, J. M., Franck, N., O’Gorman, D. J., Egan, B., Zierath, J. R., & Krook, A. (2017) · Diabetes · doi:10.2337/db17-0141 · Cited by 196
Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Shore, G., & Warr, M. (2008) · Current Molecular Medicine · doi:10.2174/156652408783769580 · Cited by 193
Nguyen, T., Kuo, C., Nicholl, M. B., Sim, M.-S., Turner, R. R., Morton, D. L., & Hoon, D. S. B. (2011) · Epigenetics · doi:10.4161/epi.6.3.14056 · Cited by 192
p120-ctn: A nexus for contextual signaling via Rho GTPases
Anastasiadis, P. Z. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.040 · Cited by 192
Plaisier, C. L., Pan, M., & Baliga, N. S. (2012) · Genome Research · doi:10.1101/gr.133991.111 · Cited by 190
Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
Amicarella, F., Muraro, M. G., Hirt, C., Cremonesi, E., Padovan, E., Mele, V, Governa, V, Han, J., Huber, X., Droeser, R. A., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310016 · Cited by 189
The MicroRNA Biology of the Mammalian Nucleus
Roberts, T. C. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.40 · Cited by 189
Yang, M.-C., Wang, H.-C., Hou, Y.-C., Tung, H.-L., Chiu, T.-J., & Shan, Y.-S. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0449-3 · Cited by 187
Wei, W., He, H.-B., Zhang, W.-Y., Zhang, H.-X., Bai, J.-B., Liu, H.-Z., Cao, J.-H., Chang, K.-C., Li, X.-Y., & Zhao, S.-H. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.184 · Cited by 183
Smith, K. M., Guerau-de-Arellano, M., Costinean, S., Williams, J. L., Bottoni, A., Mavrikis Cox, G., Satoskar, A. R., Croce, C. M., Racke, M. K., Lovett-Racke, A. E., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103171 · Cited by 181
Chung, A. C.-K., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00050 · Cited by 180
Cerione, R. A. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.01.008 · Cited by 179
Papadopoulou, A. S., Dooley, J., Linterman, M. A., Pierson, W., Ucar, O., Kyewski, B., Zuklys, S., Hollander, G. A., Matthys, P., Gray, D. H. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2193 · Cited by 177
Bakkar, N., Wang, J., Ladner, K. J., Wang, H., Dahlman, J. M., Carathers, M., Acharyya, S., Rudnicki, M. A., Hollenbach, A. D., & Guttridge, D. C. (2013) · Journal of Cell Biology · doi:10.1083/jcb.20070717908082013c · Cited by 174
Pancreatic cancer: Stroma and its current and emerging targeted therapies
Kota, J., Hancock, J., Kwon, J., & Korc, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.12.035 · Cited by 173
Self-citationSuppression of hepatic stellate cell activation by microRNA-29b
Sekiya, Y., Ogawa, T., Yoshizato, K., Ikeda, K., & Kawada, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.041 · Cited by 168
miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases
Morita, S., Horii, T., Kimura, M., Ochiya, T., Tajima, S., & Hatada, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714647 · Cited by 167
Wong, C., Wei, L., Law, C., Ho, D. W., Tsang, F. H., Au, S. L., Sze, K. M., Lee, J. M., Wong, C. C., & Ng, I. O. (2016) · Hepatology · doi:10.1002/hep.28304 · Cited by 162
E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7
Logan, N. A., Graham, A., Zhao, X., Fisher, R., Maiti, B., Leone, G. W., & Thangue, N. B. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208703 · Cited by 156
Koh, W. L. C., Sheng, C. T., Tan, B., Lee, Q. Y., Kuznetsov, V. A., Lim, S. K., & Tanavde, V. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-s1-s6 · Cited by 156
Dooley, J., Garcia‐Perez, J. E., Sreenivasan, J., Schlenner, S., Vangoitsenhoven, R., Papadopoulou, A. S., Tian, L., Schönefeldt, S., Serneels, L., Deroose, C. M., et al. (2015) · Diabetes · doi:10.2337/db15-0770 · Cited by 154
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator
Tsai, Y.-P., Chen, H.-F., Chen, S.-Y., Cheng, W.-C., Wang, H.-W., Shen, Z.-J., Song, C., Teng, S.-C., He, C., & Wu, K.-J. (2014) · Genome biology · doi:10.1186/s13059-014-0513-0 · Cited by 152
Dangerous liaisons: Pancreatic stellate cells and pancreatic cancer cells
Apte, M. V., & Wilson, J. S. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07000.x · Cited by 152
Takaku, M., Grimm, S. A., Shimbo, T., Perera, L., Menafra, R., Stunnenberg, H. G., Archer, T. K., Machida, S., Kurumizaka, H., & Wade, P. A. (2016) · Genome Biology · doi:10.1186/s13059-016-0897-0 · Cited by 151 · cited 2×
“Finally, GATA3 is a well-studied transcription factor to have potent tumor-suppressive function in various cancers, and it is known to counteract metastasis by inducing MET.170 In breast cancer cells, GATA3 mediated its tumor-suppressive role through the upregulation of miR-29b.171 Through an extensive series of exper…”
BackgroundAstrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia
Ouyang, Y., Xu, L., Lu, Y., Sun, X., Yue, S., Xiong, X., & Giffard, R. G. (2013) · Glia · doi:10.1002/glia.22556 · Cited by 144
Widespread context dependency of microRNA-mediated regulation
Erhard, F., Haas, J., Lieber, D., Malterer, G., Jaśkiewicz, Ł., Zavolan, M., Dölken, L., & Zimmer, R. (2014) · Genome Research · doi:10.1101/gr.166702.113 · Cited by 144
Fels, D. R., Ye, J., Segan, A. T., Kridel, S. J., Spiotto, M. T., Olson, M., Koong, A. C., & Koumenis, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2873 · Cited by 140
Downregulation of miR‐29 contributes to cisplatin resistance of ovarian cancer cells
Yu, P., Yan, M., Lai, H., Huang, R., Chou, Y., Lin, W., Yeh, L., & Lin, Y. (2013) · International Journal of Cancer · doi:10.1002/ijc.28399 · Cited by 138
Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network
Zhu, J., Xiong, G., Fu, H., Evers, B. M., Zhou, B. P., & Xu, R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1027 · Cited by 138
Endoplasmic reticulum proteostasis: a key checkpoint in cancer
Oakes, S. A. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00266.2016 · Cited by 137
Rivadeneira, D. B., Mayhew, C. N., Thangavel, C., Sotillo, E., Reed, C. A., Graña, X., & Knudsen, E. S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.007 · Cited by 136
Nuclear and cytoplasmic localization of neural stem cell microRNAs
Jeffries, C. D., Fried, H. M., & Perkins, D. O. (2011) · RNA · doi:10.1261/rna.2006511 · Cited by 135
Wang, L., Wang, J., Blaser, B. W., Duchemin, A.-M., Kusewitt, D. F., Liu, T., Caligiuri, M. A., & Briesewitz, R. (2007) · Blood · doi:10.1182/blood-2007-02-071266 · Cited by 134
Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
Cittelly, D. M., Finlay-Schultz, J., Howe, E. N., Spoelstra, N. S., Axlund, S. D., Hendricks, P., Jacobsen, B. M., Sartorius, C. A., & Richer, J. K. (2012) · Oncogene · doi:10.1038/onc.2012.275 · Cited by 131
Liu, A. X., Testa, J. R., Hamilton, T. C., Jove, R., Nicosia, S. V., & Cheng, J. Q. (1998) · PubMed · Cited by 130
Li, Y., Cai, B., Shen, L., Dong, Y., Lu, Q., Sun, S., Liu, S., Ma, S., Ma, P. X., & Chen, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.032 · Cited by 129
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
Amodio, N., Stamato, M. A., Gullà, A., Morelli, E., Romeo, E., Raimondi, L., Pitari, M. R., Ferrandino, I., Misso, G., Caraglia, M., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0985 · Cited by 125
Chen, H.-X., Xu, X.-X., Tan, B., Zhang, Z., & Zhou, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000460510 · Cited by 125
Schmitt, M. J., Philippidou, D., Reinsbach, S. E., Margue, C., Wienecke-Baldacchino, A. K., Nashan, D., Behrmann, I., & Kreis, S. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-41 · Cited by 123
Brenner, J. L., Jasiewicz, K. L., Fahley, A. F., Kemp, B. J., & Abbott, A. L. (2010) · Current Biology · doi:10.1016/j.cub.2010.05.062 · Cited by 123
Hashimoto, D., Bläuer, M., Hirota, M., Ikonen, N. H., Sand, J. A., & Laukkarinen, J. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.011 · Cited by 122
Muniyappa, M. K., Dowling, P., Henry, M. A., Meleady, P., Doolan, P., Gammell, P., CLYNES, M. M., & Barron, N. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.09.014 · Cited by 119
The potential of microRNAs in liver fibrosis
He, Y., Huang, C. Z., Zhang, S., Sun, X., Long, X., & Li, J. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.023 · Cited by 116
Tréhoux, S., Lahdaoui, F., Delpu, Y., Renaud, F., Leteurtre, E., Torrisani, J., Jonckheere, N., & SEUNINGEN, I. V. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.033 · Cited by 115
The regulation and function of micrornas in kidney diseases
Wei, Q., Mi, Q., & Dong, Z. (2013) · IUBMB Life · doi:10.1002/iub.1174 · Cited by 114
The role of miR-29 in pulmonary fibrosis
Cushing, L., Kuang, P., & Lü, J. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0095 · Cited by 112
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
Blandin, A.-F., Renner, G., Lehmann, M., Lelong-Rebel, I. H., Martin, S., & Dontenwill, M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00279 · Cited by 112
Decker, T. W., Schneller, F., Hipp, S., Miething, C., Jahn, T., Duyster, J., & Peschel, C. (2002) · Leukemia · doi:10.1038/sj.leu.2402389 · Cited by 111
Yang, W., Jeong, H.-J., Park, S., & Lee, W. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.05.011 · Cited by 109
microRNAs and Neurodegenerative Diseases
Qiu, L., Tan, E., & Zeng, L. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_6 · Cited by 108
Gong, J.-N., Yu, J., Lin, H.-S., Zhang, X.-H., Yin, X.-L., Xiao, Z., Wang, F., Xs, W., Su, R. J., Shen, C., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.133 · Cited by 107
Xu, W. W., Li, B., Guan, X., Chung, S. K., Wang, Y., Yip, Y. L., Law, S. Y.-K., Chan, K. T., Lee, N. P. Y., Chan, K. W., et al. (2017) · Nature Communications · doi:10.1038/ncomms14399 · Cited by 104
Bosserhoff, A., Kortylewski, M., Komyod, W., Kauffmann, M.-E., Heinrich, P. C., & Behrmann, I. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22237.x · Cited by 103
Autophagy protects LNCaP cells under androgen deprivation conditions
Li, M., Jiang, X., Liu, D., Na, Y.-Q., Gao, G., & Xi, Z. (2008) · Autophagy · doi:10.4161/auto.5209 · Cited by 101
Cristiano, B. E., Chan, J. C., Hannan, K. M., Lundie, N. A., Marmy-Conus, N., Campbell, I., Phillips, W. A., Robbie, M. J., Hannan, R. D., & Pearson, R. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1968 · Cited by 101
Cole, A. M., Myant, K., Reed, K. R., Ridgway, R. A., Athineos, D., van den Brink, G. R., Muncan, V., Clevers, H. C., Clarke, A. R., Siciński, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0315 · Cited by 100
Gong, J., Li, J., Wang, Y., Liu, C., Jia, H., Jiang, C.-L., Wang, Y., Luo, M., Zhao, H., Dong, L., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt337 · Cited by 97
Mersey, B. D., Jin, P., & Danner, D. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi368 · Cited by 96
MicroRNAs as regulators of apoptosis mechanisms in cancer
Pileczki, V., Cojocneanu, R., Maralani, M., Berindan‐Neagoe, I., & Săndulescu, R. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-512 · Cited by 94
Recombinant pre-miR-29b for Alzheimer´s disease therapeutics
Pereira, P., Tomás, J., Queiroz, J. A., Figueiras, A., & de Sousa, F. P. (2016) · Scientific Reports · doi:10.1038/srep19946 · Cited by 92
A comprehensive characterization of the nuclear microRNA repertoire of post-mitotic neurons
Khudayberdiev, S., Zampa, F., Rajman, M., & Schratt, G. M. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00043 · Cited by 89
Claerhout, S., Verschooten, L., Kelst, S. V., Vos, R. D., Proby, C. M., Agostinis, P., & Garmyn, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25300 · Cited by 88
Ru, P., Hu, P., Geng, F., Mo, X. M., Cheng, C., Yoo, J. Y., Cheng, X., Wu, X., Guo, J. Y., Nakano, I., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.017 · Cited by 87
Jagannathan, S., Vad, N. M., Vallabhapurapu, S., Vallabhapurapu, S., Anderson, K. C., & Driscoll, J. J. (2014) · Leukemia · doi:10.1038/leu.2014.279 · Cited by 86
Arias‐Romero, L. E., & Chernoff, J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.828037 · Cited by 86
Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors
Herrera-Carrillo, E., Liu, Y. P., & Berkhout, B. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2017.036 · Cited by 86
Nuclear microRNAs and their unconventional role in regulating non-coding RNAs
Liang, H., Zhang, J., Zen, K., Zhang, C., & Chen, X. (2013) · Protein & Cell · doi:10.1007/s13238-013-3001-5 · Cited by 84
MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
Teng, Y., Zhang, Y., Qu, K., Yang, X., Fu, J., Chen, W., & Li, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5695 · Cited by 79
Tan, M., Wu, J., & Cai, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.123 · Cited by 79
microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer
Rostas, J. W., Pruitt, H. C., Metge, B. J., Mitra, A., Bailey, S. K., Bae, S., Singh, K. P., Devine, D. J., Dyess, D. L., Richards, W. O., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-200 · Cited by 78
Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential
Kwon, J. J., Willy, J. A., Quirin, K. A., Wek, R. C., Korc, M., Yin, X., & Kota, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11928 · Cited by 78
Self-citationThe role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis.
Roy, S., Benz, F., Luedde, T., & Roderburg, C. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.01.05 · Cited by 77
Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer
Zhong, Y., Lu, Y., Sun, Y. J., Shi, Z., Li, N., Tang, Y., & Duan, J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1398732 · Cited by 76
Age-dependent increase of oxidative stress regulates microRNA-29 family preserving cardiac health
Heid, J., Cencioni, C., Ripa, R., Baumgart, M., Atlante, S., Milano, G., Scopece, A., Kuenne, C. T., Günther, S., Azzimato, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16829-w · Cited by 76
Li, X., Leu, S., Cheong, A., Zhang, H., Baibakov, B. A., Shih, C., Birnbaum, M. J., & Donowitz, M. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.061 · Cited by 75
Nishikawa, R., Chiyomaru, T., Enokida, H., Inoguchi, S., Ishihara, T., Matsushita, R., Goto, Y., Fukumoto, I., Nakagawa, M., & Seki, N. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.06.005 · Cited by 75
Pathophysiological role of microRNA-29 in pancreatic cancer stroma
Kwon, J. J., Nabinger, S. C., Vega, Z., Sahu, S. S., Alluri, R. K., Sater, Z. A., Yu, Z., Gore, J., Nalepa, G., Saxena, R., et al. (2015) · Scientific Reports · doi:10.1038/srep11450 · Cited by 75
Self-citationProgestin regulated miRNAs that mediate progesterone receptor action in breast cancer
Cochrane, D. R., Jacobsen, B. M., Connaghan, K. D., Howe, E. N., Bain, D. L., & Richer, J. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.020 · Cited by 72
Cited by
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
McCubrey, J. A., Yang, L. V., Abrams, S. L., Steelman, L. S., Follo, M. Y., Cocco, L., Ratti, S., Martelli, A. M., Augello, G., & Cervello, M. (2022) · Cells · doi:10.3390/cells11142155 · Cited by 49
“TP53 can induce the expression of miR-29 in certain cancers [34,39].”
BackgroundWalsh, A. D., Stone, S., Freytag, S., Aprico, A., Kilpatrick, T. J., Ansell, B. R. E., & Binder, M. D. (2023) · Communications Biology · doi:10.1038/s42003-023-04926-8 · Cited by 9
Metadata
- Authors
- Kwon, J. J., Factora, T. D., Dey, S., & Kota, J.
- Venue
- Molecular Therapy Oncolytics
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 12
- Pages
- 173-194
- ISSN
- 2372-7705 (ISSN-L)
- OpenAlex
- W2907841219
- Cited by
- 263
- References
- 244
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.